Hollings Cancer Center Researchers (IMAGE)

Medical University of South Carolina

Hollings Cancer Center Researchers

Caption

In a clinical trial, Mark Rubinstein, Ph.D., (left) and John Wrangle, M.D., used two drugs that have never been combined in humans before to slow the progression of lung cancer.

Credit

Sarah Pack, Medical University of South Carolina

Usage Restrictions

Credit Medical University of South Carolina's Hollings Cancer Center

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.